BancFirst Trust & Investment Management’s AbbVie ABBV Stock Holding History

BancFirst Trust & Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,650	Closed	-$643K	–	40
2024 Q4	$643K	Buy	3,650 +249	+7%	+$45.8K	0.29%	24
2024 Q3	$662K	Sell	3,401 -661	-16%	-$123K	0.22%	21
2024 Q2	$686K	Buy	4,062 +729	+22%	+$121K	0.32%	22
2024 Q1	$607K	Hold	3,333	–	–	0.29%	22
2023 Q4	$516K	Hold	3,333	–	–	0.24%	23
2023 Q3	$507K	Sell	3,333 -68	-2%	-$9.98K	0.25%	23
2023 Q2	$453K	Sell	3,401 -5,265	-61%	-$772K	0.26%	24
2023 Q1	$1.37M	Hold	8,666	–	–	0.82%	10
2022 Q4	$1.41M	Sell	8,666 -164	-2%	-$25.1K	0.81%	11
2022 Q3	$1.26M	Buy	8,830 +4,865	+123%	+$698K	0.75%	10
2022 Q2	$537K	Sell	3,965 -5,297	-57%	-$809K	0.41%	22
2022 Q1	$1.5M	Buy	9,262 +5,297	+134%	+$769K	0.96%	9
2021 Q4	$537K	Buy	+3,965	New	+$468K	0.41%	22

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BancFirst Trust & Investment Management's ABBV Position: Q1 2025 in Review

BancFirst Trust & Investment Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 3,650 shares — an estimated $643K sold.

BancFirst Trust & Investment Management first reported a position in ABBV in Q4 2021 and held it in 13 quarters. The position peaked at $1.5M in Q1 2022. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

BancFirst Trust & Investment Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
BancFirst Trust & Investment Management sold 3,650 AbbVie shares in Q1 2025, an estimated $643K.
BancFirst Trust & Investment Management first reported a position in AbbVie in Q4 2021 and held it in 13 quarters.
BancFirst Trust & Investment Management's AbbVie position peaked at $1.5M in Q1 2022.
3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on BancFirst Trust & Investment Management's 13F filing for Q1 2025, filed 15 Apr 2025.